Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.

[1]  Thomas Ta.  Valvular heart disease. , 1996 .

[2]  G. Hedenstierna,et al.  Ventilation‐Perfusion Inequality in Patients Undergoing Cardiac Surgery , 1994, Anesthesiology.

[3]  M. Hynynen,et al.  Pulmonary vascular effects of trinitroglycerin and isosorbide dinitrate after cardiopulmonary bypass. , 1993, British journal of anaesthesia.

[4]  R. Rodríguez-Roisín,et al.  Effect of pulmonary hypertension on gas exchange. , 1993, The European respiratory journal.

[5]  C. Clelland,et al.  In Vitro Pulmonary Vasorelaxant Effect of the Phosphodiesterase Inhibitor Enoximone , 1993, Angiology.

[6]  H. Nathan,et al.  Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. , 1992, Journal of cardiothoracic and vascular anesthesia.

[7]  H. E. von der Leyen,et al.  Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts. , 1992, Arzneimittel-Forschung.

[8]  F. Szlam,et al.  Pharmacokinetics of amrinone during cardiac surgery. , 1991, Anesthesiology.

[9]  R. N. Brogden,et al.  Enoximone. A review of its pharmacological properties and therapeutic potential. , 1991, Drugs.

[10]  R. Winkle,et al.  Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure. , 1991, American heart journal.

[11]  D. Renlund,et al.  Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. , 1991, The Journal of thoracic and cardiovascular surgery.

[12]  F. Grover,et al.  Identification of patients at greatest risk for developing major complications at cardiac surgery. , 1990, Circulation.

[13]  W. Hess.  Effects of amrinone on the right side of the heart. , 1989, Journal of cardiothoracic anesthesia.

[14]  H. Palevsky,et al.  Classification of Histologic Lesions in Primary Pulmonary Hypertension Group Medial lesions Intimal lesions Medial hypertrophy Increased smooth muscle , 2005 .

[15]  M. Michel,et al.  Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. , 1989, Journal of the American College of Cardiology.

[16]  K. J. Schwenzer,et al.  Hemodynamic Effects of Dobutamine in Patients Following Mitral Valve Replacement , 1989, Anesthesia and analgesia.

[17]  P. Binkley,et al.  Cardiovascular pharmacology of dopexamine in low output congestive heart failure. , 1988, The American journal of cardiology.

[18]  E. Sonnenblick,et al.  Newer cardiotonic agents: implications for patients with heart failure and ischemic heart disease. , 1987, Journal of cardiothoracic anesthesia.

[19]  E. Braunwald,et al.  Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. , 1986, Circulation.

[20]  Johnson Dc,et al.  Pharmacology of the bipyridines: amrinone and milrinone. , 1986 .

[21]  R. S. Mitchell,et al.  Operative risk of mitral valve replacement: discriminant analysis of 1329 procedures. , 1985, Circulation.

[22]  J Ross,et al.  Afterload mismatch in aortic and mitral valve disease: implications for surgical therapy. , 1985, Journal of the American College of Cardiology.

[23]  A. Holmgren,et al.  Effects of Nitroglycerin on Central Haemodynamics and VA/Q Distribution Early after Coronary Bypass Surgery , 1982, Acta anaesthesiologica Scandinavica.

[24]  J. Benumof,et al.  Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures. , 1975, Journal of applied physiology.

[25]  J. West,et al.  Factors determining the distribution of pulmonary blood flow in patients with raised pulmonary venous pressure. , 1969, Clinical science.

[26]  R. Riley,et al.  Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. , 1949, Journal of applied physiology.

[27]  J. Jamart,et al.  Postcardiopulmonary bypass lung edema. A preventable complication? , 1993, Chest.

[28]  N. A. Moore,et al.  Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery. , 1993, European journal of anaesthesiology. Supplement.

[29]  D. Loisance,et al.  Cost-effectiveness in patients awaiting transplantation receiving intravenous inotropic support. , 1993, European journal of anaesthesiology. Supplement.

[30]  R. Naeije,et al.  Pulmonary hemodynamic response to dopamine and dobutamine in hyperoxic and in hypoxic dogs. , 1987, Anesthesiology.

[31]  M. Scheinman,et al.  Catheter ablation for treatment of tachyarrhythmias: present role and potential promise. , 1986, Circulation.

[32]  M. Mcgregor,et al.  On pulmonary vascular resistance: the need for more precise definition. , 1985, The American journal of cardiology.